Regulatory Compliant – no royalty fees
The CHO-GS expression system enables rapid identification of clones expressing high levels of recombinant therapeutic protein during development of a stable cell line. Flexible licensing term ensures that access to this high-performance cell line platform is easily accessible to meet the demands for cost effective biomanufacturing.
The CHO-GS expression system consists of:
- 1 vial of 10x106 cGMP Horizon CHO cells
- A Dual promoter expression vector
- Protocols and technical support
- Traceability documentation detailing the derivation of the cells and adventitious agents testing results to support regulatory filings
To discuss your bioproduction/biomanufacturing cell line needs and to find out how we can meet them, please contact us.